Contract facts
NONEADMINISTRATIVE CORRECTION is a federal NONE award for Nac Federal Supply Schedule (36F797) held by Actelion Pharmaceuticals Us, Inc. Estimated value —. Related solicitation 65IB.
Incumbent footprint
Public recordActelion Pharmaceuticals Us, Inc — $5.4M obligated across 106 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36F79724D0159?
36F79724D0159 (Administrative correction) is a Nac Federal Supply Schedule (36F797) award with an estimated value of —, currently held by Actelion Pharmaceuticals Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36F797-24-D-0159?
36F797-24-D-0159 is the dashed form of PIID 36F79724D0159 (Administrative correction), held by Actelion Pharmaceuticals Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36F79724D0159?
Nac Federal Supply Schedule (36F797) awarded 36F79724D0159 to Actelion Pharmaceuticals Us, Inc.
Who is the incumbent on 36F79724D0159?
Actelion Pharmaceuticals Us, Inc is the incumbent with $5.4M across 106 related awards in SCOUT’s public footprint.
When does Actelion Pharmaceuticals Us, Inc’s 36F79724D0159 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.